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Background
Human immunodeficiency virus type-I (HIV-1) envelope
glycoprotein (Env) mediates the first step of entry and
represents an attractive target . However, the genetic
diversity of Env among HIV-1 subtypes poses a challenge.
Although evidence suggest that entry inhibitors in clinical
use have comparable efficacy against HIV-1 subtypes, but
a subset of anti-Env are resistant to HIV-1 subtype C
which is the most globally prevalent virus. In a view to
prevent infection of HIV-1 subtype C, we isolated nucleic
acids ligands aptamers against HIV-1 subtype C Env pseu-
dovirion and tested their efficacy.
Methods
We isolated 109 unique 2`F-RNA aptamer sequences
against HIV-1 subtype C Env pseudovirus using systematic
evolution of ligands by exponential enrichment (SELEX)
process. After 9 selex cycles, we grouped aptamer clones
by binding activity to gp120 then selected one of the apta-
mer which neutralized infection of parental virus with
IC50 values <5 nM. We tested efficacy of a selected apta-
mer against 31-pseudovirus panel from subtype C using
single cycle luciferase assay in TZM-bl cells. In addition,
we mapped the epitope on gp120 binding by competition.
Results
When screened on a 31-panel of HIV-1 subtype C pseu-
doviruses, RNA aptamer CSIR 1.1, neutralized 26 /31
(84%) with mean IC50 of 6.7 ± 8.8 nM. Competition
ELISA results revealed CSIR 1.1 bind to the epitope over-
lapping CD4 and VRC01 on monomeric gp120 but not
b12 or b6. In contrast to CD4, CSIR 1.1 did not enhance
the binding of 17 b to the co-receptor region on mono-
meric gp120 showing a different binding mode to the
soluble CD4.
Conclusion
Our data show that we have isolated new RNA aptamers
with efficacy against diverse HIV-1 subtype C viruses. The
immediate future research would include testing efficacy
on primary isolates and precise mapping.
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